JHG Targeted Variant(s)
GTR Test Accession: Help GTR000569184.3
INHERITED DISEASE
Last updated in GTR: 2024-08-30
Last annual review date for the lab: 2024-08-30 LinkOut
At a Glance
Diagnosis; Mutation Confirmation
Hereditary disease
Molecular Genetics - Targeted variant analysis: Bi-directional Sanger Sequence Analysis
Not provided
Not provided
Not provided
Ordering Information
Offered by: Help
Johns Hopkins Genomics DNA Diagnostic Laboratory
View lab's website
View lab's test page
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
Test Order Code: Help
Targeted Variant(s)
View other test codes
CPT codes: Help
**AMA CPT codes notice
Lab contact: Help
Hannah Shultz-Lutwyche, BS, Genetic Counselor Assistant
hlutwyc1@jhmi.edu
410-955-0483
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Submit sample with completed requisition form
Order URL
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
Confirmation of research findings
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Yes
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Chromosomal regions/Mitochondria Help
Total chromosomal regions/mitochondria: 1
Chromosomal region/Mitochondrion Associated condition
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Targeted variant analysis
Bi-directional Sanger Sequence Analysis
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Mutation Confirmation
Variant Interpretation:
What is the protocol for interpreting a variation as a VUS? Help
Bioinformatic and clinical evidence are weighed and recommendations for followup to help determine clinical significance are made. ACMG/AMP guidelines used for variant classification.

Are family members with defined clinical status recruited to assess significance of VUS without charge? Help
Yes. Our VUS resolution program involves targeting additional family members for a VUS, with the intention of this additional information aiding in reclassification of the variant. In order to qualify for our VUS resolution program, your patient must have at least one VUS listed on a test report that was issued … View more

Will the lab re-contact the ordering physician if variant interpretation changes? Help
Decline to answer.
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
> 99% accuracy for nucleotides evaluated; our analysis parameters are not designed to detect mosaicism.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Intra-Laboratory
VUS:
Laboratory's policy on reporting novel variations Help
Variants of uncertain significance are typically called if personal contact information for the physician or genetic counselor has been provided on the requisition form.
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: FDA exercises enforcement discretion
Additional Information
Practice guidelines:
Consumer resources:

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.